Trinseo (TSE) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Nov, 2025Executive summary
Q3 2025 net loss was $110 million, with adjusted EBITDA at $30 million, impacted by unfavorable raw material timing, negative equity income from Americas Styrenics, and weak demand, partially offset by restructuring savings.
Net sales declined 14% year-over-year to $743 million, mainly due to lower volumes and margin compression, especially in Europe.
Announced discontinuation of virgin MMA production in Italy and planned closure of a German polystyrene facility, targeting $30 million annualized profitability improvement and $10 million in capital expenditure reduction.
Major restructuring and refinancing actions were implemented, including suspension of the dividend and extension of debt maturities to 2028, to preserve liquidity.
Strategic focus on growth platforms and recycling initiatives, with pilot plants for recycled polycarbonate, ABS, and MMA sold out and plans to scale up.
Financial highlights
Q3 2025 adjusted EBITDA was $30 million, with net sales of $743 million and a net loss of $110 million; gross margin was 5%.
Free cash flow for Q3 was negative $38 million; quarter-end liquidity was $346 million, with cash of $112–114 million.
Operating loss for Q3 was $28 million; interest expense was $71 million.
Adjusted EBITDA margin was 4% for Q3 2025.
Total debt at September 30, 2025 was $2.57 billion.
Outlook and guidance
Q4 2025 adjusted EBITDA expected at $30–$40 million, with a projected net loss of $170–$180 million and positive free cash flow of $20 million.
Year-end liquidity is forecasted at $350–$365 million.
FY 2025 net loss forecasted at $408–418 million and adjusted EBITDA at $167–177 million.
Management remains focused on cost savings, inventory management, and restructuring to improve free cash flow.
Free cash flow in Q4 is expected to improve sequentially due to working capital release from year-end seasonality.
Latest events from Trinseo
- Q4 saw a $251M net loss, 19% sales drop, flat EBITDA, and ongoing restructuring challenges.TSE
Q4 202513 Mar 2026 - Q2 2024 Adjusted EBITDA hit a two-year high, with positive free cash flow expected in H2.TSE
Q2 20242 Feb 2026 - Q3 net loss of $87M, but Adjusted EBITDA rose $25M; liquidity and restructuring improved outlook.TSE
Q3 202415 Jan 2026 - Q4 2024 delivered higher EBITDA and cash flow, but losses persist amid weak demand and restructuring.TSE
Q4 20242 Dec 2025 - Shareholders will vote on directors, compensation, auditor, share issuance, and plan amendments.TSE
Proxy Filing1 Dec 2025 - Shareholders will vote on directors, executive pay, auditor, share issuance, and incentive plan changes.TSE
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and share issuance authority.TSE
Proxy Filing1 Dec 2025 - Q2 2025 net loss and sales decline persist, but cost actions and liquidity measures support outlook.TSE
Q2 202524 Nov 2025 - Adjusted EBITDA rose to $65M in Q1 2025, driven by licensing income and cost savings.TSE
Q1 202522 Nov 2025